Liadov V K, Egiev V N, Volkov S V, Korobkov A O, Liadov K V
Khirurgiia (Mosk). 2014(9):17-22.
Vessels resection in case of pancreatic head cancer may be associated with portal vein thrombosis. System AngioJet 9000 (Possis Medical Inc.) for rheolytic thrombectomy is one of endovascular device for treatment of patients with venous thrombosis. Descriptions of 3 cases with rheolytic thrombectomy using are presented in the article. Percutaneous transhepatic approach under ultrasound control was used for visualization of portal vein branches. Stent-grafts were implanted in 2 of 3 cases after thrombectomy in zone of portal vein thrombosis. Bleeding from liver puncture site was observed in 1 case in early postoperative period. There was not recurrent thrombosis in long-term postoperative period (31 months after surgery maximally). The authors consider that use of several endovascular techniques such as rheolytic thrombectomy with stenting or without it provides satisfactory clinical results in treatment of patients with postoperative portal vein thrombosis.
胰头癌病例中的血管切除可能与门静脉血栓形成有关。用于血栓溶解切除术的System AngioJet 9000（Possis Medical Inc.）是治疗静脉血栓形成患者的一种血管内装置。本文介绍了3例使用血栓溶解切除术的病例。在超声控制下采用经皮经肝途径来观察门静脉分支。3例中有2例在门静脉血栓形成区域进行血栓切除术后植入了覆膜支架。术后早期有1例出现肝穿刺部位出血。术后长期（最长术后31个月）未出现复发性血栓形成。作者认为，使用多种血管内技术，如带支架或不带支架的血栓溶解切除术，在治疗术后门静脉血栓形成患者时可提供令人满意的临床效果。
